IL2 and asthenia: THD has synergistic and additive antiemetic, anti-asthenia, and analgesic effects of corticosteroids 57, 58; it inhibits the expression of cytokines without affecting levels of IL-2, IL-4, and IL-10 59, 60, thus offering the possibility of steroid-sparing or steroid-replacement therapy.